To develop a model to assess the cost-efficacy of the implantable cardioverter defibrillator to prevent sudden death. The model must be sufficiently flexible to allow the use of cost and survival figures derived from different sources.
Implications for present and future applications of the implantable cardioverter-defibrillator resulting from the use of a simple model of cost efficacy.
